PeerVoice Heart & Lung Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

subscribe
share






Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data


Visit https://www.peervoice.com/TWQ860 to view the entire programme with slides. After completing “Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data”, participants will be able to: Explain the rationale for targeted therapy in early-stage EGFR-mutant NSCLC; Assess recent clinical data for EGFR tyrosine kinase inhibitors (TKIs) as adjuvant therapy for patients with early-stage EGFR-mutant NSCLC; and Describe how EGFR TKIs may impact the treatment paradigm for early-stage EGFR-mutant NSCLC.


fyyd: Podcast Search Engine
share








 November 4, 2020  18m